Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
ROCKVILLE, MD, April 19, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
David Hovland, Ph.D., to serve as Chief Regulatory Officer and Bryan Smith, J.D. as General…
Daix (France), April 19, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA) is pleased to…
Daix (France), April 19, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
AGOURA HILLS, Calif., April 19, 2021 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the…
BURBANK, CA, April 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a…
04_19_2021 PR Image The Embroidered Hiking Backpack This Product Line is Comprised of Embroidered: Hiking…
First 10 patients dosed in 77 patient randomized, double blind, placebo controlled Phase 2 Clinical…
Florham Park, NJ, April 19, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
Presentations will highlight new data on the safety, efficacy, and tolerability of once-daily, topical roflumilast…
Webinar on Tuesday, April 27th @ 1pmET CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) —…
RICOVR Healthcare announced that it has raised $1.5 million in funding to commercialize its point-of-care…
LAS VEGAS, NV, April 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One World Pharma…
TurboCAR Technology Allows a Programmable Cytokine Signaling to Potentially Control T Cell Exhaustion and Improve…
Submission has been made for review under the accelerated approval pathway LEXINGTON, Mass., April 19,…
SHANGHAI, China, April 19, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (“ECMOHO” or the “Company”; Nasdaq:…
PRESS RELEASE April 19, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
KIELPIN, Poland, April 19, 2021 (GLOBE NEWSWIRE) — Celon Pharma S.A. today announced that it…
New preclinical data from GLP toxicology and biodistribution study demonstrates in vivo safety of KB407…